Early research (Phase 1)Study completedNCT04265027
What this trial is testing
Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC)
Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 72